This announcement is a separate document:
贵州百灵:董事会对会计师事务所出具2023年度带强调事项段的保留意见审计报告的专项说明
Guizhou Bailing Group Pharmaceutical: Special note by the board of directors on the 2023 audit report with reservations issued by accounting firms with highlighted sections
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.